ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 162 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,027,985 | +89.5% | 50,170 | +58.4% | 0.00% | – |
Q2 2023 | $542,525 | 0.0% | 31,671 | 0.0% | 0.00% | – |
Q1 2023 | $542,525 | -48.2% | 31,671 | -40.8% | 0.00% | -100.0% |
Q4 2022 | $1,046,428 | -99.8% | 53,471 | +36.6% | 0.00% | – |
Q3 2022 | $624,642,000 | +16.0% | 39,138 | 0.0% | 0.00% | – |
Q2 2022 | $538,538,000 | -13.2% | 39,138 | 0.0% | 0.00% | – |
Q1 2022 | $620,728,000 | -27.3% | 39,138 | 0.0% | 0.00% | – |
Q4 2021 | $854,382,000 | -39.8% | 39,138 | -17.6% | 0.00% | -100.0% |
Q3 2021 | $1,419,179,000 | -34.4% | 47,480 | -2.8% | 0.00% | 0.0% |
Q2 2021 | $2,163,656,000 | +30.6% | 48,852 | +30.8% | 0.00% | 0.0% |
Q1 2021 | $1,656,777,000 | -14.8% | 37,340 | +5.3% | 0.00% | 0.0% |
Q4 2020 | $1,945,229,000 | +139.9% | 35,471 | 0.0% | 0.00% | – |
Q3 2020 | $810,868,000 | +23.4% | 35,471 | +13.0% | 0.00% | – |
Q2 2020 | $657,013,000 | +206.6% | 31,391 | +233.5% | 0.00% | – |
Q4 2019 | $214,262,000 | +14.8% | 9,414 | -24.3% | 0.00% | – |
Q2 2019 | $186,570,000 | – | 12,438 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 715,880 | $9,851,000 | 11.04% |
RTW INVESTMENTS, LP | 15,802,802 | $217,447,000 | 5.62% |
Amitell Capital Pte Ltd | 97,331 | $1,339,000 | 3.05% |
Prosight Management, LP | 276,802 | $3,809,000 | 3.00% |
TANG CAPITAL MANAGEMENT LLC | 1,265,900 | $17,419,000 | 2.64% |
Affinity Asset Advisors, LLC | 250,466 | $3,446,000 | 1.45% |
COWEN AND COMPANY, LLC | 1,000,000 | $13,760,000 | 1.33% |
Boxer Capital, LLC | 1,466,051 | $20,173,000 | 1.28% |
Cormorant Asset Management, LP | 868,550 | $11,951,000 | 0.90% |
MAVERICK CAPITAL LTD | 2,532,366 | $34,845,000 | 0.86% |